Fig 1.
Patient disposition and subgroups of interest.
Fig 2.
Number of patients with PNH during study period and proportion of patients treated with C5 inhibitors.
Table 1.
Main sociodemographic and clinical characteristics.
Fig 3.
Treatment patterns of patients initiating a C5 inhibitor (n = 218) – Sunburst representation.